Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents.

Shirude, Pravin S; Paul, Beena; Roy Choudhury, Nilanjana; Kedari, Chaitanya; Bandodkar, Balachandra; Ugarkar, Bheemarao G

Shirude, Pravin S; Paul, Beena; Roy Choudhury, Nilanjana; Kedari, Chaitanya; Bandodkar, Balachandra; Ugarkar, Bheemarao G.

Afiliación

Shirude PS; Department of Medicinal Chemistry, AstraZeneca India Pvt. Ltd. , Avishkar, Bellary Road, Bangalore-560024, India.
Paul B; Department of Medicinal Chemistry, AstraZeneca India Pvt. Ltd. , Avishkar, Bellary Road, Bangalore-560024, India.
Roy Choudhury N; Department of Medicinal Chemistry, AstraZeneca India Pvt. Ltd. , Avishkar, Bellary Road, Bangalore-560024, India.
Kedari C; Department of Medicinal Chemistry, AstraZeneca India Pvt. Ltd. , Avishkar, Bellary Road, Bangalore-560024, India.
Bandodkar B; Department of Medicinal Chemistry, AstraZeneca India Pvt. Ltd. , Avishkar, Bellary Road, Bangalore-560024, India.
Ugarkar BG; Department of Medicinal Chemistry, AstraZeneca India Pvt. Ltd. , Avishkar, Bellary Road, Bangalore-560024, India.

ACS Med Chem Lett ; 3(9): 736-40, 2012 Sep 13.

Article en En | MEDLINE | ID: mdl-24900541

Palabras clave

NDH-2; antituberculosis; quinolinyl pyrimidines; respiratory chain

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2012 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google